Impressive growth leads to expansion at Biotec Services

Biotec Services International, the global provider of temperature controlled packaging and distribution services for clinical trials, is doubling its capacity with the addition of new processing facilities, following impressive growth.
The UK-headquartered company is expanding into additional operational, packaging and storage facilities on the back of 15 per cent growth in the last year.

As a result of increased client demand and significant contract wins, Biotec Services is increasing its controlled room temperature storage by 100 per cent and its cold room storage by 400 per cent. It is also creating a second advanced therapeutic medicinal products (ATMP) facility.

Providing support to hundreds of clinical trial and commercial projects for clients across the world, Biotec Services has built an impressive reputation for its cold chain packaging and distribution services across a full temperature range from controlled ambient down to minus 196°C.

Dr Fiona Withey, Chief Executive Officer of Biotec Services, said: "We have an exciting pipeline of work and an increasing number of phase III trials with larger storage requirements, which has resulted in a need to expand our temperature controlled packaging and storage facilities.

"Feedback from our recent client survey indicated that refrigerated storage at +2°C to +8°C is the range that most suits our partners' requirements so we are developing our facilities in line with this and also bespoke temperature demands.

"The investment demonstrates our continued commitment to developing innovative solutions to meet our clients' clinical supplies requirements."

As part of the company's strategic growth plans, it has also acquired land adjacent to the current Biotec Services' facilities, which will be developed in-line with client demands.

Dr Withey, continued: "We have ambitious objectives for the next three years as we move towards achieving our vision of becoming the market leader in cold chain clinical trial services, headquartered in the UK with a global presence. We will be looking to continue to develop our services for existing customers and to grow more and more partnerships worldwide, tackling new markets. With these plans in mind, we have secured land adjoining our current facilities to accommodate our future growth."

Led by CEO Dr Fiona Withey, Biotec Services International was established in 1997 and is now a leading global provider of temperature controlled clinical trial services including import, QP certification, labelling, assembly, storage and distribution of clinical trial supplies. The company operates from a purpose-built GMP facility licensed by the MHRA. It works with a global client base ranging from virtual companies to blue chip international pharmaceutical and healthcare companies to conduct trials from Phase I to Phase IV.

Suggested Articles

Akero's FGF21 analog beat placebo at reducing liver fat in patients with nonalcoholic steatohepatitis (NASH).

Amgen has become the latest biopharma to try to figure out the hit it may take to its pipeline timings amid the COVID-19 pandemic.

The database was locked at the end of February but will only be unblinded after the FDA has provided feedback.